Acute interstitial nephritis after sequential ipilumumab - nivolumab therapy of metastatic melanoma

Acute interstitial nephritis after sequential ipilumumab - nivolumab therapy of metastatic melanoma

Abstract Background The anti-Programmed Death receptor 1 (anti-PD-1) antibodies nivolumab and pembrolizumab are new treatments in metastatic melanoma. Immunotherapies are best known to be responsible for thrombotic microangiopathy. However, immune interstitial nephritis has been described in a patie...

Full description

Bibliographic Details
Main Authors: Lea Bottlaender, Anne-Laure Breton, Louis de Laforcade, Frederique Dijoud, Luc Thomas, Stephane Dalle
Format: Article
Language:English
Published: BMJ Publishing Group 2017-07-01
Series:Journal for ImmunoTherapy of Cancer
Subjects:
Pd-1
Melanoma
Acute kidney injury
Acute interstitial immune nephritis
Immunotherapy
Online Access:http://link.springer.com/article/10.1186/s40425-017-0261-2

Internet

http://link.springer.com/article/10.1186/s40425-017-0261-2

Similar Items